47 related articles for article (PubMed ID: 24123048)
1. Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
Pan XB; Lu Y; Wei YS; Yao DS
BMC Cancer; 2024 Jan; 24(1):106. PubMed ID: 38238689
[TBL] [Abstract][Full Text] [Related]
2. The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee.
Ikeda M; Shida M; Shigeta S; Nagase S; Takahashi F; Yamagami W; Katabuchi H; Yaegashi N; Aoki D; Mikami M
J Gynecol Oncol; 2021 May; 32(3):e44. PubMed ID: 33825359
[TBL] [Abstract][Full Text] [Related]
3. Effect of changes in treatment practice on survival for cervical cancer: results from a population-based study in Manitoba, Canada.
Kang YJ; O'Connell DL; Lotocki R; Kliewer EV; Goldsbury DE; Demers AA; Canfell K
BMC Cancer; 2015 Sep; 15():642. PubMed ID: 26394749
[TBL] [Abstract][Full Text] [Related]
4. Prognostic analysis of stage IIIC1p cervical cancer patients.
Gao T; Yang Z; Wei L; Tang X; Ma S; Jiang L; Zhang Y; Wu F
Front Oncol; 2024; 14():1362281. PubMed ID: 38725620
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Effects of Base of Tongue Concurrent Chemoradiation Therapy in a Pre-Clinical Model.
Benedict PA; Kravietz A; Yang J; Achlatis E; Doyle C; Johnson AM; Dion GR; Amin MR
Laryngoscope; 2023 Jun; 133(6):1455-1461. PubMed ID: 36134872
[TBL] [Abstract][Full Text] [Related]
6. Presence of low volume metastases does not alter management in node-negative, early-stage cervical cancer patients who underwent postoperative adjuvant therapy: A retrospective cohort study.
Welp AM; Crawford M; O'Brien R; Sullivan SA; Duska LR
Gynecol Oncol Rep; 2024 Feb; 51():101320. PubMed ID: 38188187
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features and Prognostic Factors of Cervical Clear Cell Adenocarcinoma: A Retrospective Analysis of 74 Cases from a Tertiary Hospital.
Liu Y; Shi X; Yang J; Zhou H; Peng P; Cao D
Technol Cancer Res Treat; 2023; 22():15330338221149297. PubMed ID: 36718531
[TBL] [Abstract][Full Text] [Related]
8. Comparison of platinum monotherapy with concurrent chemoradiation therapy versus platinum-based dual drug therapy with concurrent chemoradiation therapy for locally advanced cervical cancer: a systematic review and meta-analysis.
Deng T; Gu S; Wu J; Yu Y
Infect Agent Cancer; 2022 Apr; 17(1):18. PubMed ID: 35440034
[TBL] [Abstract][Full Text] [Related]
9. Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.
Qin F; Pang H; Yu T; Luo Y; Dong Y
Technol Cancer Res Treat; 2022; 21():15330338221086403. PubMed ID: 35341413
[TBL] [Abstract][Full Text] [Related]
10. Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival.
Noh KW; Kim B; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS; Cho WK; Park W; Lee YY
Cancer Res Treat; 2022 Jan; 54(1):245-252. PubMed ID: 33857364
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-128 Confers Anti-Endothelial Adhesion and Anti-Migration Properties to Counteract Highly Metastatic Cervical Cancer Cells' Migration in a Parallel-Plate Flow Chamber.
Chuang PC; Lu CW; Tsai CC; Tseng SH; Su WH
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379338
[TBL] [Abstract][Full Text] [Related]
12. Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy.
Zhong ML; Wang YN; Liang MR; Liu H; Zeng SY
Int J Gynecol Cancer; 2020 May; 30(5):602-606. PubMed ID: 32156715
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy.
Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Oh YT; Kang SH
BMC Cancer; 2017 Apr; 17(1):297. PubMed ID: 28454573
[TBL] [Abstract][Full Text] [Related]
14. Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.
Lee YY; Park W; Huh SJ; Yoon A; Park JY; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
Anticancer Res; 2013 Oct; 33(10):4675-81. PubMed ID: 24123048
[TBL] [Abstract][Full Text] [Related]
15. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
Ryu HS; Chun M; Chang KH; Chang HJ; Lee JP
Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
[TBL] [Abstract][Full Text] [Related]
17. Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
Lee HN; Lee KH; Lee DW; Lee YS; Park EK; Park JS
Int J Gynecol Cancer; 2011 Jan; 21(1):128-36. PubMed ID: 21330837
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
19. Integrating Chemotherapy in the Management of Cervical Cancer: A Critical Appraisal.
Kumar L; Gupta S
Oncology; 2016; 91 Suppl 1():8-17. PubMed ID: 27464068
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
